leukemia
Immune System Kills Cancer
Immune System Kills Cancer
Kate Yandell | Mar 27, 2013
T-cells engineered to attack B-cells sent adults’ acute leukemia into remission.
Little Cancer Risk from Fukushima
Little Cancer Risk from Fukushima
Jef Akst | Mar 1, 2013
A new report from the World Health Organization predicts only very minimal increases in cancer risk for residents in the vicinity of the nuclear disaster.
Ancient Viruses Wreak New Havoc
Ancient Viruses Wreak New Havoc
Beth Marie Mole | Oct 24, 2012
Viral DNA in mice genomes may lead to cancer in immune-compromised animals.
CT Scans Increase Risk of Cancer
Edyta Zielinska | Jun 7, 2012
Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.
Designing Transition-State Inhibitors
Designing Transition-State Inhibitors
Vern L. Schramm | May 1, 2012
A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 
Freezing Time
Vern L. Schramm | May 1, 2012
Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.
Telomeres in Disease
Rodrigo Calado and Neal Young | May 1, 2012
Telomeres have been linked to numerous diseases over the years, but how exactly short telomeres cause diseases and how medicine can prevent telomere erosion are still up for debate.
Are Cancer Stem Cells Ready for Prime Time?
Are Cancer Stem Cells Ready for Prime Time?
Suling Liu, Hasan Korkaya, and Max S. Wicha | Apr 1, 2012
A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.
Turning T-cells into Cancer Killers
Tia Ghose | Aug 10, 2011
Repurposing patient’s own T-cells to recognize antigens on cancer cells caused dramatic improvement in three patients with chronic lymphocytic leukemia.
Stem Cells Hit Reverse
Tia Ghose | Jul 31, 2011
A transcription factor can make adult stem cells behave like fetal stem cells.